Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC26A10P ("Solute carrier family 26 member 10, pseudogene") is annotated as a human pseudogene belonging to the SLC26 family of anion transporters[3][1]. While bona fide SLC26 family members facilitate membrane anion exchange—playing roles in electrolyte homeostasis and diseases[1]—SLC26A10P itself does not produce a functional protein and is therefore not involved in any known biological processes, molecular transport, or pathologies in humans[3]. The pseudogene status means it is considered a nonfunctional genomic remnant with sequence similarity to active members of the SLC26 family. SLC26A10P should not be confused with SLC26A10, which in some databases is also identified as a pseudogene[1][3]. The solute carrier (SLC) superfamily contains numerous functional transporters, many of which do play key roles in physiology and are considered therapeutic targets[1][4], but SLC26A10P is not among them. About 30% of annotated SLCs are "orphan" (unknown substrate/function)[4]; however, pseudogenes like SLC26A10P are specifically annotated as nonfunctional and are excluded from therapeutic targeting efforts[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 26 member 10, pseudogene (SLC26A10P).